Celularity
CELU
27 hedge funds and large institutions have $2.86M invested in Celularity in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
1,217% more call options, than puts
Call options by funds: $237K | Put options by funds: $18K
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
4% more funds holding
Funds holding: 26 → 27 (+1)
0.05% more ownership
Funds ownership: 4.34% → 4.39% (+0.05%)
3% less capital invested
Capital invested by funds: $2.96M → $2.86M (-$92.2K)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$37.1K |
| 2 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$34.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$14.1K |
| 4 |
CA
CoreCap Advisors
Southfield,
Michigan
|
+$1.47K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$12K |
| 2 |
Renaissance Technologies
New York
|
-$6.24K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$5.79K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$3.13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.13K |
CELU Hedge Fund Activity: Q3 2024 in Review
27 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2024, worth a combined $2.86M — down 3.1% from $2.96M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CELU positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $37.1K. The largest seller was Geode Capital Management, cutting an estimated $12K.
- 27 institutional investors held Celularity (CELU) as of Q3 2024, up from 26 in Q2 2024.
- Funds reported $2.86M of Celularity stock for Q3 2024, down 3.1% quarter-over-quarter.
- 3 funds opened new Celularity positions in Q3 2024 and 2 closed out, a net change of +1 holder.
- The largest Celularity buyer in Q3 2024 was BlackRock, an estimated $37.1K added.
- The largest Celularity seller in Q3 2024 was Geode Capital Management, an estimated $12K sold.
Based on aggregated 13F filings for Q3 2024.